106 related articles for article (PubMed ID: 26165647)
1. Farnesoid X receptor knockdown provides significant growth inhibition in hepatocellular carcinoma cells while it does not interfere with the proliferation of primary human hepatocyte-derived cells.
Fujino T; Maruko-Ohtake A; Ohtake Y; Kobayashi T; Ando K; Takeuchi A; Ohkubo Y; Hayakawa M
J Toxicol Sci; 2015 Aug; 40(4):501-8. PubMed ID: 26165647
[TBL] [Abstract][Full Text] [Related]
2. Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation.
Fujino T; Takeuchi A; Maruko-Ohtake A; Ohtake Y; Satoh J; Kobayashi T; Tanaka T; Ito H; Sakamaki R; Kashimura R; Ando K; Nishimaki-Mogami T; Ohkubo Y; Kitamura N; Sato R; Kikugawa K; Hayakawa M
J Biochem; 2012 Dec; 152(6):577-86. PubMed ID: 22969091
[TBL] [Abstract][Full Text] [Related]
3. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line.
Fujino T; Sakamaki R; Ito H; Furusato Y; Sakamoto N; Oshima T; Hayakawa M
J Toxicol Sci; 2017; 42(3):259-265. PubMed ID: 28496032
[TBL] [Abstract][Full Text] [Related]
5. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells.
Liu XC; Lian W; Zhang LJ; Feng XC; Gao Y; Li SX; Liu C; Cheng Y; Yang L; Wang XJ; Chen L; Wang RQ; Chai J; Chen WS
PLoS One; 2015; 10(8):e0136215. PubMed ID: 26292095
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
14. [Effect of RhoC on hepatocellular carcinoma cell growth and related molecular mechanisms].
Xie SL; Zhu MG; Lü GY; Wang GY
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):270-5. PubMed ID: 21575497
[TBL] [Abstract][Full Text] [Related]
15. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
[TBL] [Abstract][Full Text] [Related]
16. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification.
Awasthi N; Wagner BJ
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4482-9. PubMed ID: 17003443
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
Lv BH; Zhang L; Zhu CC; Liu J
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
[TBL] [Abstract][Full Text] [Related]
20. The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.
Cheng F; McLaughlin PJ; Verderame MF; Zagon IS
Mol Biol Cell; 2009 Jan; 20(1):319-27. PubMed ID: 18923142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
